PLSE stock news · Pulse Biosciences, Inc.
Get alerts for PLSE
Follow Pulse Biosciences, Inc. (PLSE) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for PLSEPulse Biosciences, Inc. says it has signed up 164 patients for its heart study.
Good for PLSEPulse Biosciences reached its planned enrollment for a heart-rhythm device study, a positive step toward results. The study has not yet shown whether the device is safe or effective.
TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine, and other big stocks climbed on Wednesday.
Good for PLSEPulse Biosciences received a new Buy initiation from BTIG with a $70 price target, which adds a fresh positive analyst view on the company's prospects.
An analyst starts following HCA Healthcare with a positive outlook and shares the top 5 picks for Wednesday.
Good for PLSEPulse Biosciences was started at Buy with a $70 target, which increases analyst coverage and positive visibility for the company.
Pulse Biosciences, Inc. has entered into a significant definitive agreement, as detailed in its Form 8-K (PLSE).
NeutralPulse Biosciences, Inc. has filed a Form 8-K indicating its entry into a material definitive agreement, which is likely to have significant implications for its business strategy and financial outlook. This development is expected to positively influence investor sentiment and stock performance.